来源：生物谷    2013-03-04

美国FDA目前正在审核一种由Depomed公司和Hisamitsu公司联合研制的新药。这种新药能够有效治疗更年期潮热并没有显着的副作用。据报道，这种药物是目前第一种治疗该症的非激素类药物。

详细英文报道：

Staffers at the FDA weighed in new drugs from Depomed and Hisamitsu Pharmaceutical for combating post-menopausal hot flashes, saying that the drugs showed efficacy while raising no new red flags on safety, Reuters reported. Depomed shares spiked yesterday as the company races with Hisamitsu to garner the first FDA approvals of non-hormonal drugs for tempering hot flashes, even though Depomed's drug fell short of efficacy goals in trials.